Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel

  • H. H. Cheng
  • , R. Gulati
  • , A. Azad
  • , R. Nadal
  • , P. Twardowski
  • , U. N. Vaishampayan
  • , N. Agarwal
  • , E. I. Heath
  • , S. K. Pal
  • , H. T. Rehman
  • , A. Leiter
  • , J. A. Batten
  • , R. B. Montgomery
  • , M. D. Galsky
  • , E. S. Antonarakis
  • , K. N. Chi
  • , E. Y. Yu

Research output: Contribution to journal › Article › peer-review

81 Scopus citations

Fingerprint

Dive into the research topics of 'Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience